**Core Concept**
The Diabetes Control and Complications Trial (DCCT) was a landmark study that demonstrated the benefits of intensive glucose control in reducing the risk of microvascular complications in patients with type 1 diabetes mellitus (T1DM). This trial provided conclusive evidence that chronic hyperglycemia is a major risk factor for the development of microvascular complications, such as nephropathy, retinopathy, and neuropathy.

**Why the Correct Answer is Right**
The DCCT study showed that intensive insulin therapy, which aimed to maintain near-normal blood glucose levels, significantly reduced the risk of microvascular complications in patients with T1DM. This was achieved by tightly controlling blood glucose levels, which in turn reduced the levels of advanced glycosylation end-products (AGEs), activated protein kinase C (PKC), and other factors that contribute to the development of microvascular damage. The study's findings have since been confirmed by subsequent trials, including the United Kingdom Prospective Diabetes Study (UKPDS) and the Kumamoto study.

**Why Each Wrong Option is Incorrect**
**Option B:** This option is incorrect because, although the DCCT did provide evidence for the benefits of intensive glucose control in patients with T1DM, the question specifies "type 1 DM," and option B is a repeat of the correct answer.
**Option C:** This option is incorrect because the DCCT did not primarily focus on type 2 diabetes mellitus (T2DM); rather, it focused on patients with T1DM. While the study's findings have implications for patients with T2DM, the primary outcome was related to T1DM.
**Option D:** This option is incorrect because the DCCT did not provide definitive proof for the reduction of macrovascular complications in type 2 DM. The study primarily focused on microvascular complications in patients with T1DM.

**Clinical Pearl / High-Yield Fact**
It is essential to remember that the DCCT's findings have significant implications for the management of patients with diabetes. Tight glucose control, achieved through intensive insulin therapy or other means, can significantly reduce the risk of microvascular complications and improve patient outcomes. This knowledge should guide clinical decision-making in the management of patients with diabetes.

**✓ Correct Answer: A. Microvascular complications of type 1 DM**